Cargando…

Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities

OBJECTIVES. Examine age differences in SARS-CoV-2 transmission risk from primary cases and infection risk among household contacts, and symptoms among those with SARS-CoV-2 infection. METHODS. People with SARS-CoV-2 infection in Nashville, Tennessee and central and western Wisconsin and their househ...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLean, Huong Q., Grijalva, Carlos G., Hanson, Kayla E., Zhu, Yuwei G., Deyoe, Jessica E., Meece, Jennifer K., Halasa, Natasha B., Chappell, James D., Mellis, Alexandra, Reed, Carrie, Belongia, Edward A., Talbot, H. Keipp, Rolfes, Melissa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382134/ https://www.ncbi.nlm.nih.gov/pubmed/34426817 http://dx.doi.org/10.1101/2021.08.16.21262121

Ejemplares similares

Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection — Tennessee and Wisconsin, April–September 2020
por: Rolfes, Melissa A., et al.
Publicado: (2021)

Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020
por: Grijalva, Carlos G., et al.
Publicado: (2020)

Performance of Self-Collected Anterior Nasal Swabs and Saliva Specimens for Detection of SARS-CoV-2 During Symptomatic and Asymptomatic Periods
por: Grijalva, Carlos G, et al.
Publicado: (2021)

67. SARS-CoV-2 Transmission: Preliminary Findings from a Household-based Study
por: Grijalva, Carlos G, et al.
Publicado: (2020)

2293. Examining social vulnerability and its effect on COVID-19 transmission in households
por: Goodman, Sara H, et al.
Publicado: (2023)

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023
por: McLean, Huong Q., et al.
Publicado: (2023)

432. High concordance between self-collected nasal swabs and saliva samples for detection of SARS-CoV-2
por: Grijalva, Carlos G, et al.
Publicado: (2020)

400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study
por: Floris-Moore, Michelle, et al.
Publicado: (2023)

925. Oseltamivir usage in community settings: data from a household transmission study
por: Mellis, Alexandra, et al.
Publicado: (2023)

2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
por: Mellis, Alexandra, et al.
Publicado: (2023)

2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection
por: Rolfes, Melissa A, et al.
Publicado: (2023)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
por: McLean, Huong Q., et al.
Publicado: (2014)

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial
por: McLean, Huong Q., et al.
Publicado: (2015)

School absenteeism among school‐aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012‐2013 through 2014‐2015
por: McLean, Huong Q., et al.
Publicado: (2017)

Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
por: Petrie, Joshua G., et al.
Publicado: (2023)

Serious outcomes of medically attended, laboratory‐confirmed influenza illness among school‐aged children with and without asthma, 2007‐2018
por: McLean, Huong Q., et al.
Publicado: (2020)

Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
por: King, Jennifer P., et al.
Publicado: (2021)

Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States
por: Patel, Manish, et al.
Publicado: (2020)

1142. Impact of Informational Vaccine Notices Sent to Parents Prior to their Child’s 11(th) Birthday on Receipt of Adolescent Vaccines
por: Hanson, Kayla E, et al.
Publicado: (2023)

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents
por: Hanson, Kayla E., et al.
Publicado: (2019)

Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas
por: Boyce, Thomas G., et al.
Publicado: (2022)

446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort
por: Sundaram, Maria, et al.
Publicado: (2023)

Estimated Hospitalization Rates for Seasonal Influenza in Adults and Children in Middle Tennessee using a Capture-Recapture Method
por: Ivey, Kelsey S, et al.
Publicado: (2017)

Validation of self‐reported influenza vaccination in the current and prior season
por: King, Jennifer P., et al.
Publicado: (2018)

Earliest infections predict the age distribution of seasonal influenza A cases
por: Arevalo, Philip, et al.
Publicado: (2020)

930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment
por: Smith-Jeffcoat, Sarah E, et al.
Publicado: (2023)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

1056 Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children
por: King, Jennifer, et al.
Publicado: (2014)

1057 Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years
por: Mclean, Huong, et al.
Publicado: (2014)

Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults
por: Talbot, H Keipp, et al.
Publicado: (2015)

991. Randomized Trial of High Dose, Adjuvanted, and Standard Inactivated Influenza Vaccine Immune Response Against Egg- and Cell-Propagated Vaccine Strains in Older Adults, 2016–2017 Season
por: McLean, Huong, et al.
Publicado: (2018)

Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers
por: Goessl, Cody L., et al.
Publicado: (2022)

1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period — IVY Network, 5 U.S. States, April 11, 2022 – February 1, 2023
por: Raglow, Zoe M, et al.
Publicado: (2023)

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
por: Poehling, Katherine A, et al.
Publicado: (2018)

2212. Burden of Community-Acquired Pneumonia Attributable to Co-morbid Conditions in Adults
por: Rolfes, Melissa A, et al.
Publicado: (2019)

Impact of Age and Symptom Development on SARS-CoV-2 Transmission in Households With Children—Maryland, New York, and Utah, August 2020–October 2021
por: Sumner, Kelsey M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vgbdl7rh9gbnmgfmvoc6mf1hm0